Position in UTHR
as of Jun 30, 2026
· filed Jul 27, 2026
Position Value
$752,060
+$224,308 QoQ
Shares Held
1,388
+56.0% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#505
of 875 holders
Holding Since
Sep 2023
4 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in UTHR Over Time
Shares Held
Position Value (USD)
Derivatives in UTHR
reported options exposure · as of Sep 30, 2023CallValue
$22,135
CallShares
9,800
PutValue
$9,938
PutShares
4,400
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Private Advisor Group, LLC holds $6,097,763 across 11 Drug Manufacturers - Specialty & Generic names. UTHR ranks #4 (12.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | HIMS |
Hims & Hers Health, Inc.
|
45,162 | $1,565,766 | |
| 2 | ZTS |
Zoetis Inc.
|
14,568 | $1,046,856 | |
| 3 | AMRX |
Amneal Pharmaceuticals, Inc.
|
57,998 | $1,003,945 | |
| 4 | UTHR |
UNITED THERAPEUTICS Corp
This page
|
1,388 | $752,060 | |
| 5 | TEVA |
Teva Pharmaceutical Industries Ltd
|
18,399 | $623,358 | |
| 6 | VTRS |
Viatris Inc
|
35,520 | $564,057 | |
| 7 | HLN |
Haleon plc
|
29,818 | $278,201 | |
| 8 | 32,381 | $102,323 |
All Filings in UTHR
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $752,060 | 1,388 | Shares | Sole | 2026-07-27 | |
| 2026-03-31 | $527,752 | 890 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $426,343 | 875 | Shares | Sole | 2026-02-17 | |
| 2023-09-30 | $24,168 | 107 | Shares | Sole | 2023-11-03 | |
| 2023-09-30 | $22,135 | 9,800 | Call | Sole | 2023-11-03 | |
| 2023-09-30 | $9,938 | 4,400 | Put | Sole | 2023-11-03 | |
| No filing history on record for this holder in this stock. | ||||||